3 December, 2024AAVantgarde Bio announces FDA Orphan Drug Designation for AAVB-081 for the treatment of Usher Syndrome type 1B Retinitis Pigmentosa
19 November, 2024Women's Health Company Freya Biosciences Announces Key $10.4 Million Strategic Investment
18 November, 2024Cure51 Launches NHS-Approved Study With Cambridge University Hospitals and Seven Other Leading UK Oncology Institutions to Unlock Cancer Survival Secrets
18 November, 2024BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations
31 October, 2024TechBio startup Cure51 selects 10x Genomics Visium HD for new drug discovery initiative